Clarius Group LLC’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $219K | Hold |
2,755
| – | – | 0.01% | 359 |
|
|
2025
Q3 | $208K | Sell |
2,755
-856
| -24% | -$58.7K | 0.01% | 378 |
|
|
2025
Q2 | $249K | Buy |
3,611
+418
| +13% | +$27.4K | 0.01% | 410 |
|
|
2025
Q1 | $216K | Sell |
3,193
-1,923
| -38% | -$115K | 0.01% | 442 |
|
|
2024
Q4 | $230K | Buy |
5,116
+1,487
| +41% | +$83.4K | 0.02% | 392 |
|
|
2024
Q3 | $223K | Sell |
3,629
-5,128
| -59% | -$299K | 0.02% | 399 |
|
|
2024
Q2 | $517K | Sell |
8,757
-721
| -8% | -$45.1K | 0.04% | 209 |
|
|
2024
Q1 | $756K | Sell |
9,478
-1,667
| -15% | -$127K | 0.05% | 161 |
|
|
2023
Q4 | $880K | Buy |
11,145
+112
| +1% | +$7.97K | 0.07% | 140 |
|
|
2023
Q3 | $770K | Sell |
11,033
-1,582
| -13% | -$112K | 0.07% | 143 |
|
|
2023
Q2 | $872K | Buy |
12,615
+158
| +1% | +$11.2K | 0.07% | 156 |
|
|
2023
Q1 | $926K | Sell |
12,457
-499
| -4% | -$41.8K | 0.08% | 139 |
|
|
2022
Q4 | $1.21M | Buy |
12,956
+696
| +6% | +$67.2K | 0.11% | 115 |
|
|
2022
Q3 | $1.17M | Buy |
12,260
+518
| +4% | +$51.3K | 0.12% | 106 |
|
|
2022
Q2 | $1.09M | Buy |
11,742
+385
| +3% | +$37.6K | 0.11% | 119 |
|
|
2022
Q1 | $1.17M | Hold |
11,357
| – | – | 0.09% | 120 |
|
|
2021
Q4 | $1.17M | Buy |
11,357
+306
| +3% | +$28.3K | 0.09% | 120 |
|
|
2021
Q3 | $938K | Buy |
11,051
+466
| +4% | +$39K | 0.08% | 129 |
|
|
2021
Q2 | $883K | Buy |
10,585
+109
| +1% | +$8.93K | 0.08% | 134 |
|
|
2021
Q1 | $788K | Buy |
10,476
+1,325
| +14% | +$96.5K | 0.08% | 132 |
|
|
2020
Q4 | $625K | Buy |
9,151
+1,266
| +16% | +$82.3K | 0.07% | 142 |
|
|
2020
Q3 | $460K | Sell |
7,885
-6,853
| -46% | -$426K | 0.06% | 147 |
|
|
2020
Q2 | $958K | Buy |
14,738
+4,627
| +46% | +$291K | 0.13% | 83 |
|
|
2020
Q1 | $600K | Buy |
10,111
+1,547
| +18% | +$103K | 0.11% | 94 |
|
|
2019
Q4 | $645K | Buy |
8,564
+925
| +12% | +$64.9K | 0.1% | 102 |
|
|
2019
Q3 | $482K | Buy |
7,639
+1,838
| +32% | +$109K | 0.09% | 122 |
|
|
2019
Q2 | $316K | Buy |
5,801
+1,567
| +37% | +$84.4K | 0.06% | 164 |
|
|
2019
Q1 | $228K | Buy |
+4,234
| New | +$261K | 0.06% | 181 |
|
|
2018
Q4 | – | Sell |
-2,803
| Closed | -$221K | – | 127 |
|
|
2018
Q3 | $221K | Sell |
2,803
-2,006
| -42% | -$143K | 0.08% | 112 |
|
|
2018
Q2 | $309K | Buy |
+4,809
| New | +$317K | 0.13% | 62 |
|
|
2016
Q3 | – | Sell |
-2,190
| Closed | -$210K | – | 96 |
|
|
2016
Q2 | $210K | Hold |
2,190
| – | – | 0.11% | 81 |
|
|
2016
Q1 | $227K | Buy |
2,190
+88
| +4% | +$8.56K | 0.13% | 74 |
|
|
2015
Q4 | $205K | Buy |
+2,102
| New | +$206K | 0.12% | 74 |
|
Other funds holding CVS
Clarius Group LLC's CVS Position: Q4 2025 in Review
Clarius Group LLC held its CVS Health (CVS) position steady in Q4 2025 at 2,755 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #359.
Clarius Group LLC first reported a position in CVS in Q4 2015 and has held it in 33 quarters since. The position peaked at $1.21M in Q4 2022. 1,946 funds tracked by Wall St. Rank hold CVS as of Q4 2025.
- Clarius Group LLC held 2,755 shares of CVS Health worth $219K as of Q4 2025.
- Clarius Group LLC left its CVS Health share count unchanged in Q4 2025.
- CVS Health made up 0.01% of Clarius Group LLC's portfolio in Q4 2025, its #359 holding.
- Clarius Group LLC first reported a position in CVS Health in Q4 2015 and has held it in 33 quarters since.
- Clarius Group LLC's CVS Health position peaked at $1.21M in Q4 2022.
- 1,946 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.
Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.